0A2M Stock Overview
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Koninklijke Philips N.V. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €22.70 |
52 Week High | €28.85 |
52 Week Low | €17.71 |
Beta | 0.78 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | 9.74% |
3 Year Change | -57.02% |
5 Year Change | n/a |
Change since IPO | -46.65% |
Recent News & Updates
Recent updates
Shareholder Returns
0A2M | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | 0% | 4.1% | 2.7% |
1Y | 9.7% | -7.9% | 5.2% |
Return vs Industry: 0A2M exceeded the UK Medical Equipment industry which returned -7.9% over the past year.
Return vs Market: 0A2M exceeded the UK Market which returned 5.2% over the past year.
Price Volatility
0A2M volatility | |
---|---|
0A2M Average Weekly Movement | 6.5% |
Medical Equipment Industry Average Movement | 6.7% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0A2M has not had significant price volatility in the past 3 months.
Volatility Over Time: 0A2M's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1891 | 69,656 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
0A2M fundamental statistics | |
---|---|
Market cap | US$24.16b |
Earnings (TTM) | -US$856.16m |
Revenue (TTM) | US$19.56b |
1.2x
P/S Ratio-28.2x
P/E RatioIs 0A2M overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0A2M income statement (TTM) | |
---|---|
Revenue | €18.14b |
Cost of Revenue | €10.63b |
Gross Profit | €7.51b |
Other Expenses | €8.30b |
Earnings | -€794.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 29, 2024
Earnings per share (EPS) | -0.87 |
Gross Margin | 41.38% |
Net Profit Margin | -4.38% |
Debt/Equity Ratio | 63.8% |
How did 0A2M perform over the long term?
See historical performance and comparison